Literature DB >> 2136071

Assessment of procedural learning and problem solving in schizophrenic patients by Tower of Hanoi type tasks.

T E Goldberg1, J A Saint-Cyr, D R Weinberger.   

Abstract

Two versions of the Tower of Hanoi task were used to investigate different components of learning and problem solving in schizophrenia. Prior studies have suggested that a three-disk version (Tower 3), which involves primarily problem-solving abilities and planning, is preferentially sensitive to frontal lobe lesions and that the more difficult four-disk version (Tower 4), which involves "learning by doing," is sensitive to basal ganglia disease. Schizophrenic patients performed significantly worse than normal subjects on Tower 3 and Tower 4. However, they performed at least as well relatively on Tower 4 as on Tower 3, indicating that level of difficulty per se does not account for their poor performance on these tasks. Moreover, they eventually attained perfect or near-perfect performance after four days of repeated administration. Their relatively stronger performance on Tower 4 may have reflected an ability to acquire a procedure and, as such, suggests greater preservation of basal ganglia function than of prefrontal function.

Entities:  

Mesh:

Year:  1990        PMID: 2136071     DOI: 10.1176/jnp.2.2.165

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  21 in total

1.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings.

Authors:  Thomas W Weickert; Terry E Goldberg; Michael F Egan; Jose A Apud; Martijn Meeter; Catherine E Myers; Mark A Gluck; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

3.  Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man.

Authors:  V Kumari; P J Corr; O F Mulligan; P A Cotter; S A Checkley; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

4.  More than just tapping: index finger-tapping measures procedural learning in schizophrenia.

Authors:  Felipe N Da Silva; Farzin Irani; Jan Richard; Colleen M Brensinger; Warren B Bilker; Raquel E Gur; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-02-16       Impact factor: 4.939

Review 5.  Functional imaging in Huntington's disease.

Authors:  Jane S Paulsen
Journal:  Exp Neurol       Date:  2009-01-03       Impact factor: 5.330

6.  Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers.

Authors:  J M Danion; S Peretti; D Grangé; M Bilik; J L Imbs; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Cognitive deficits in psychiatric disorders: Current status.

Authors:  J K Trivedi
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

8.  Impaired implicit learning in schizophrenia.

Authors:  William P Horan; Michael F Green; Barbara J Knowlton; Jonathan K Wynn; Jim Mintz; Keith H Nuechterlein
Journal:  Neuropsychology       Date:  2008-09       Impact factor: 3.295

Review 9.  Reward processing in schizophrenia: a deficit in the representation of value.

Authors:  James M Gold; James A Waltz; Kristen J Prentice; Sarah E Morris; Erin A Heerey
Journal:  Schizophr Bull       Date:  2008-06-30       Impact factor: 9.306

10.  Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.

Authors:  Scot E Purdon; Neil Woodward; Stacy R Lindborg; Emmanuel Stip
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.